Ace the CNOR 2025 Challenge – Master the Operating Room with Confidence!

Malignant hyperthermia is a serious and life-threatening reaction that can occur in response to certain anesthetic agents, particularly those used during general anesthesia, such as volatile anesthetics and succinylcholine. This condition is characterized by a sudden increase in muscle metabolism, which leads to rapid and uncontrolled rise in body temperature, muscle rigidity, and an increased rate of metabolism, potentially resulting in severe complications if not treated promptly.

During episodes of malignant hyperthermia, calcium is released excessively from the sarcoplasmic reticulum of skeletal muscle, which leads to increased energy consumption, resulting in metabolic acidosis, hypercarbia, and significant muscle damage. The condition necessitates immediate medical intervention, typically with the administration of dantrolene, which helps to restore normal muscle function by reducing calcium release from muscle cells.

Understanding malignant hyperthermia is crucial for healthcare professionals, particularly those in anesthesiology and the operating room, as prompt identification and treatment can be lifesaving. This is why the definition focusing on its nature as a life-threatening reaction to certain anesthetics and its associated symptoms is accurate and critical for the safety of patients undergoing surgical procedures.